~~<i id='959B6C5CA4'><strike id='959B6C5CA4'><tt id='959B6C5CA4'><pre id='959B6C5CA4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

Wikipedia

author：entertainment 2025-09-29 00:39:10 - browse：71194

For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight over who held patent rights to CRISPR-Cas9, the revolutionary genome editing tool.

Editas Medicine, the winner of that battle in the U.S., will now cash in.

Vertex Pharmaceuticals and Editas announced Wednesday that Vertex will pay Editas $50 million, along with a series of annual payments through 2034, in exchange for rights to use CRISPR-Cas9 in Casgevy, the sickle cell therapy approved last week.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： An innovative path out of biotech’s “valley of death”

focus

knowledge

entertainment

focus

Wikipedia

IsWegovythefutureofcardiology?CanNovoNordiskevermakeenoughofit?AndwillthereeverbeanAppleofpharma?Wec

WSS

How housing is health care on Long Island

FDA approves updated Covid vaccines

Faced with fears of OxyContin misuse, sales reps touted its safety

An innovative path out of biotech’s “valley of death”

CDC overhauls leadership of center that led response to Covid

Food makers to regulators: Ultra

focus

Wikipedia

focus

Anesthesiologist group: stop taking Ozempic before surgery

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Psychedelics group wrestles with new pharma identity

An innovative path out of biotech’s “valley of death”

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Kim Kardashian sparks debate on benefits of full

Medicare details structure of new drug price negotiation program

Where are patients getting their prescriptions for GLP

Alkermes shareholders re

Listen: Your guide to Wegovy's blockbuster heart study

knowledge

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Private equity could exacerbate cardiology's overuse problem, experts fear

Walmart eyes Medicare Advantage provider ChenMed

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Private equity could exacerbate cardiology's overuse problem, experts fear

WATCH: Why do bright lights make us see spots?

entertainment

focus

focus

Wikipedia